Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

344.25
+7.312.17%
Post-market: 344.00-0.2500-0.07%17:45 EDT
Volume:653.06K
Turnover:221.81M
Market Cap:24.32B
PE:44.08
High:344.92
Open:333.57
Low:331.99
Close:336.94
52wk High:386.00
52wk Low:223.83
Shares:70.65M
Float Shares:69.93M
Volume Ratio:1.65
T/O Rate:0.93%
Dividend:0.87
Dividend Rate:0.25%
EPS(TTM):7.81
EPS(LYR):6.79
ROE:19.09%
ROA:11.38%
PB:8.13
PE(LYR):50.70

Loading ...

This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com

Dow Jones
·
Apr 24

Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceutical Services (WST)

TIPRANKS
·
Apr 24

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Apr 24

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires Live
·
Apr 23

West Pharmaceutical Shares up 15.9% Premarket After Co Raises 2026 Profit Forecast

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Exec Says Co Has Factored in Rising Oil, Commodity Prices in Updated Outlook, Taking Steps to Offset the Increase - Conf Call

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Exec Says Co Expects Net Impact of Single-Digit Millions After Mitigation Efforts - Conf Call

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Exec Says Co Saw Greater-Than-Expected Revenue Due to Anticipation of Transaction, No Pull-Forward Linked to Middle East Conflict - Conf Call

THOMSON REUTERS
·
Apr 23

S&P 500 Futures Drop In Premarket Trading; Houlihan Lokey, Medpace Holdings Lag

Dow Jones
·
Apr 23

Stock Track | West Pharmaceutical Soars 9.33% in Pre-Market on Strong Q1 Results and Raised Guidance

Stock Track
·
Apr 23

West Pharma lifts 2026 profit forecast on strong demand for medical equipment

Reuters
·
Apr 23

West Pharmaceutical sees Q2 adjusted EPS $2.05-$2.12, consensus $2.00

TIPRANKS
·
Apr 23

West Pharmaceutical ups FY26 adjusted EPS view to $8.40-$8.75 from $7.85-$8.20

TIPRANKS
·
Apr 23

West Pharmaceutical reports Q1 adjusted EPS $2.13, consensus $1.68

TIPRANKS
·
Apr 23

GUIDANCE: (WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B - $3.35B, vs. FactSet Est of $3.25B

MT Newswires Live
·
Apr 23

West Pharmaceutical Servs Q1 Adj. EPS $2.13 Beats $1.68 Estimate, Sales $844.900M Beat $779.974M Estimate

Benzinga Earnings
·
Apr 23

West Pharmaceutical Services Inc - Q2 Net Sales Guidance $830-$850 Mln, up 8.3%-10.9% Reported

THOMSON REUTERS
·
Apr 23

West Reports First-Quarter 2026 Results

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Q1 EPS USD 1.92

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Services Inc - Effective in Q1 2026, Co Renamed "Contract-Manufactured Products" Reportable Segment to "West Vantage"

THOMSON REUTERS
·
Apr 23